CAS 2201056-66-6

AG-270

CAS : 2201056-66-6

Formule : C₃₀H₂₇N₅O₂

Degré de pureté : 97%

Couleur et forme : Solid

Masse moléculaire : 489.5677

Ref: IN-DA01V79K

3-(Cyclohex-1-En-1-Yl)-6-(4-Methoxyphenyl)-2-Phenyl-5-(Pyridin-2-Ylamino)Pyrazolo[1,5-A]Pyrimidin-7(4H)-One

CAS : 2201056-66-6

3-(Cyclohex-1-En-1-Yl)-6-(4-Methoxyphenyl)-2-Phenyl-5-(Pyridin-2-Ylamino)Pyrazolo[1,5-A]Pyrimidin-7(4H)-One

Degré de pureté : 97%

Masse moléculaire : 489.57g/mol

Ref: 54-OR1023844

AG-270

CAS : 2201056-66-6

AG-270

Degré de pureté : ≥98%

Masse moléculaire : 489.57g/mol

Ref: 54-BUP03781

AG-270

CAS : 2201056-66-6

AG-270 is an allosteric and orally active inhibitor of MAT2A.

Formule : C₃₀H₂₇N₅O₂

Degré de pureté : 98.28% - 98.87%

Couleur et forme : Solid

Masse moléculaire : 489.57

Ref: TM-T9050

AG-270

CAS : 2201056-66-6

AG-270 is a small molecule that binds to the extracellular domain of the human angiotensin II type 1 receptor. It inhibits the receptor from binding with angiotensin II and prevents the activation of downstream signaling pathways, thereby blocking the effects of angiotensin II. AG-270 is a research tool that can be used in cell biology and pharmacology studies.

Formule : C₃₀H₃₁N₅O₂

Degré de pureté : Min. 95%

Masse moléculaire : 493.6 g/mol

Ref: 3D-BND05666